From first-in-human studies to post-market surveillance, ClinRM delivers integrated pharmacovigilance, medical affairs, and regulatory support across the US, EU, and beyond — protecting patients while advancing your program.
At ClinRM, effective safety management starts with sound clinical judgment — not just compliance checklists. Our physician executives and industry specialists evaluate risk pragmatically, ensuring every decision protects patients and advances your program.
Guided by integrity and collaboration, our team transforms complex safety challenges into clear, confident decisions. With operations across the US, EU, and India, we offer multilingual services in English, Spanish, French, Dutch, Polish, German, Italian, and Portuguese — ensuring clarity and consistency across every market.
Physician executives and clinical specialists with 20+ years of hands-on drug development and safety leadership.
Pharmacovigilance, medical affairs, and regulatory strategy working as one cohesive function — not separate silos.
We work as an extension of your team, bringing the right expertise to each challenge at every stage of development.
ClinRM partners with biotech startups, emerging biopharma, and established organizations navigating critical development transitions — including companies entering US or EU markets for the first time.
4+ Regions Covered
Our physician-led team brings hands-on clinical and regulatory experience grounded in real development challenges.
We give honest, evidence-based guidance — even when it's not what clients want to hear. Trust is built on transparency, not just results.
Open, direct communication at every stage, so you always understand the rationale behind every recommendation.
Patient safety is never negotiable. Every recommendation is guided by one principle: protecting the people your therapy is designed to help.
Let's discuss how we can support your safety and regulatory needs — from early development through commercialization.
Get in Touch